LOX and acute lymphoblastic leukemia: Probst et al. (2017) reported that lipoxygenase (LOX) inhibitors, such as NDGA, protect acute lymphoblastic leukemia (ALL) cells from RSL3-stimulated lipid peroxidation, reactive oxygen species generation (ROS) and cell death [36].